Suchergebnisse - "Suto, Hirotaka"

PubPharm (28)

1

Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib

enthalten in: Endocrine journal | 2024

von Fukuda, N. | Toda, K. | Suto, H. | +9

2

Slowly Progressive Bone Marrow Metastasis of Gastric Cancer Followed-up Without Treatment

enthalten in: In vivo (Athens, Greece) | 2023

von Suto, H. | Inui, Y. | Okamura, A.

3

Is CT or FDG-PET more useful for evaluation of the treatment response in metastatic HER2-positive breast cancer? a case report and literature review

enthalten in: Frontiers in oncology | 2023

von Suto, H. | Inui, Y. | Okamura, A.

4

Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

enthalten in: Oncology | 2023

von Fukuda, N. | Oki, R. | Suto, H. | +9

5

Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment : A retrospective study

enthalten in: PloS one | 2023

von Ohmoto, A. | Nakano, K. | Fukuda, N. | +17

6

Late-onset doxorubicin-induced congestive heart failure in an elderly cancer survivor : A case report

enthalten in: Frontiers in cardiovascular medicine | 2023

von Suto, H. | Suto, M. | Inui, Y. | +1

7

Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors

enthalten in: Journal of the Endocrine Society | 2023

von Fujita, Y. | Kamitani, F. | Yamamoto, M. | +20

8

Delayed diagnosis of bladder cancer in a patient with autosomal dominant polycystic kidney disease

enthalten in: Journal of cancer research and therapeutics | 2023

von Suto, H. | Inui, Y. | Nishikawa, S. | +1

9

Difficulty in Distinguishing Pulmonary Arterial Intimal Sarcoma from Pulmonary Thromboembolism Using FDG PET/CT

enthalten in: In vivo (Athens, Greece) | 2022

von Suto, H. | Suto, M. | Inui, Y. | +1

10

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge

enthalten in: Molecular and clinical oncology | 2022

von Nose, T. | Funakoshi, Y. | Suto, H. | +5